FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.

The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, especially for young people, and experts say there's little evidence that they help adults quit smoking.

For the first time, the Food and Drug Administration has authorized the marketing and sale of popular nicotine patches, saying the products could help some smokers kick the habit. In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

The U.S. Food and Drug Administration (FDA) has announced the authorization of 20 ZYN nicotine pouch products through its premarket tobacco product application (PMTA) pathway. This landmark